TY - JOUR
T1 - Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis
AU - Singal, Amit G.
AU - Tiro, Jasmin A.
AU - Murphy, Caitlin C.
AU - Blackwell, James Michael
AU - Kramer, Jennifer R.
AU - Khan, Aisha
AU - Liu, Yan
AU - Zhang, Song
AU - Phillips, Jessica L.
AU - Hernaez, Ruben
N1 - Funding Information:
Funding This work was conducted with support from National Cancer Institute (R01 CA212008) and Cancer Prevention Research Institute of Texas (RP150587). The work is also supported in part by the Center for Gastrointestinal Development, Infection, and Injury (National Institute of Diabetes and Digestive and Kidney Diseases P30 DK 56338) and by the Center for Innovations in Quality, Effectiveness and Safety (CIN 13-413), Michael E. DeBakey VA Medical Center, Houston, Texas. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health, Department of Veterans Affairs, or the U.S. government, or the Cancer Prevention Research Institute of Texas.
Publisher Copyright:
© 2021 AGA Institute
PY - 2021/5
Y1 - 2021/5
N2 - Background: More than 20% of patients with cirrhosis do not receive semi-annual hepatocellular carcinoma (HCC) surveillance as recommended. Few studies have evaluated the effects of patient-level factors on surveillance receipt. Methods: We administered a telephone survey to a large cohort of patients with cirrhosis from 3 health systems (a tertiary care referral center, a safety-net health system, and Veterans Affairs) to characterize patient knowledge, attitudes, and perceived barriers of HCC surveillance. Multinomial logistic regression was performed to identify factors associated with HCC surveillance receipt (semi-annual and annual vs none) during the 12-month period preceding survey administration. Results: Of 2871 patients approached, 1020 (35.5%) completed the survey. Patients had high levels of concern about developing HCC and high levels of knowledge about HCC. However, patients had knowledge deficits, including believing surveillance was unnecessary when physical examination and laboratory results were normal. Nearly half of patients reported barriers to surveillance, including costs (28.9%), difficulty scheduling (24.1%), and transportation (17.8%). In the year before the survey, 745 patients (73.1%) received 1 or more surveillance examination; 281 received on-schedule, semi-annual surveillance and 464 received annual surveillance. Semi-annual HCC surveillance (vs none) was significantly associated with receipt of hepatology subspecialty care (odds ratio, 30.1; 95% CI, 17.5–51.8) and inversely associated with patient-reported barriers (odds ratio, 0.62; 95% CI, 0.41–0.94). Patterns of associations comparing annual vs no surveillance were similar although the magnitude of effects were reduced. Conclusions: Patient-reported barriers such as knowledge deficits, costs, difficulty scheduling, and transportation are significantly associated with less frequent receipt of HCC surveillance, indicating a need for patient-centered interventions, such as patient navigation.
AB - Background: More than 20% of patients with cirrhosis do not receive semi-annual hepatocellular carcinoma (HCC) surveillance as recommended. Few studies have evaluated the effects of patient-level factors on surveillance receipt. Methods: We administered a telephone survey to a large cohort of patients with cirrhosis from 3 health systems (a tertiary care referral center, a safety-net health system, and Veterans Affairs) to characterize patient knowledge, attitudes, and perceived barriers of HCC surveillance. Multinomial logistic regression was performed to identify factors associated with HCC surveillance receipt (semi-annual and annual vs none) during the 12-month period preceding survey administration. Results: Of 2871 patients approached, 1020 (35.5%) completed the survey. Patients had high levels of concern about developing HCC and high levels of knowledge about HCC. However, patients had knowledge deficits, including believing surveillance was unnecessary when physical examination and laboratory results were normal. Nearly half of patients reported barriers to surveillance, including costs (28.9%), difficulty scheduling (24.1%), and transportation (17.8%). In the year before the survey, 745 patients (73.1%) received 1 or more surveillance examination; 281 received on-schedule, semi-annual surveillance and 464 received annual surveillance. Semi-annual HCC surveillance (vs none) was significantly associated with receipt of hepatology subspecialty care (odds ratio, 30.1; 95% CI, 17.5–51.8) and inversely associated with patient-reported barriers (odds ratio, 0.62; 95% CI, 0.41–0.94). Patterns of associations comparing annual vs no surveillance were similar although the magnitude of effects were reduced. Conclusions: Patient-reported barriers such as knowledge deficits, costs, difficulty scheduling, and transportation are significantly associated with less frequent receipt of HCC surveillance, indicating a need for patient-centered interventions, such as patient navigation.
KW - Barriers
KW - Early Detection
KW - Knowledge
KW - Liver Cancer
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=85102433986&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102433986&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2020.06.049
DO - 10.1016/j.cgh.2020.06.049
M3 - Article
C2 - 32629122
AN - SCOPUS:85102433986
SN - 1542-3565
VL - 19
SP - 987-995.e1
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 5
ER -